Booming Growth in Artificial Pacemaker 2027
An artificial pacemaker is a small device that sends electrical pulses to the heart to maintain regularity of the heart rhythm. These can be implantable or used externally. Implantable pacemakers are extensively used over the external pacemakers. Increasing prevalence of atrial fibrillation is driving the growth of artificial pacemaker market.
The artificial pacemaker market is driving due to increasing prevalence and recurrence of cardiovascular disorders, changing lifestyle, increasing burden of non-communicable diseases, and technological advancements. However, high cost of pacemaker is expected to hamper the growth of the global artificial pacemaker market. Moreover, increasing healthcare expenditure in developing countries is anticipated to drive demand the growth of the market.
The report analyzes factors affecting artificial pacemaker market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the artificial pacemaker market in these regions.
Companies Profiled in this report includes::
Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK,
Inc., MicroPort Scientific Corp, MEDICO S.p.A., Pacetronix, Lepu Medical
Technology (Beijing) Co. Ltd., Vitatron, Edwards Lifesciences Corporation
Comments
Post a Comment